中华胃肠外科杂志
中華胃腸外科雜誌
중화위장외과잡지
CHINESE JOURNAL OF GASTROINTESTINAL SURGERY
2015年
4期
349-353
,共5页
申占龙%叶颖江%张鑫%谢启伟%尹慕军%杨晓东%姜可伟%梁斌%王杉
申佔龍%葉穎江%張鑫%謝啟偉%尹慕軍%楊曉東%薑可偉%樑斌%王杉
신점룡%협영강%장흠%사계위%윤모군%양효동%강가위%량빈%왕삼
直肠肿瘤%直肠前切除术%经腹会阴联合切除术%复发%生存
直腸腫瘤%直腸前切除術%經腹會陰聯閤切除術%複髮%生存
직장종류%직장전절제술%경복회음연합절제술%복발%생존
Rectal neoplasms%Anterior resection%Abdominoperineal resection%Recurrence%Survival
目的:比较低位直肠癌经腹会阴联合切除术(APR)和前切除术(AR)后的临床疗效。方法回顾性分析北京大学人民医院1998年1月至2010年12月间接受APR(151例,APR组)和AR(158例,AR组)术式的低位直肠癌患者的临床资料,比较两组短期结局指标、局部复发率、总生存率及无进展生存率。结果 APR组较AR组患者的手术时间长[(268.5±66.7) min比(247.4±64.2) min,P=0.005],术中出血量[(668.5±680.1) ml比(441.8±478.6) ml,P=0.001]和术后引流量多[(66.9±54.7) ml比(49.0±45.9) ml,P=0.002]。两组患者局部复发率的差异无统计学意义( P=0.188),但对于T3~T4期患者,APR组患者的5年局部复发率(24.9%)明显高于AR组(13.9%)(P=0.038)。肿瘤下缘距肛门4~6 cm的T3~T4期APR组患者的5年局部复发率(27.5%)明显高于AR组(13.0%)(P=0.038)。两组的总生存率和无进展生存率的差异均无统计学意义(均P>0.05);但当体质量指数大于或等于24 kg/m2时,APR组T3~T4期患者的5年总生存率(43.1%)和无进展生存率(42.8%)均明显低于AR组(87.9%和76.9%,P=0.022和P=0.041)。结论低位直肠癌APR和AR术后患者总体预后相当,但当患者肿瘤位于距肛缘4~6 cm、T3~T4分期和肥胖时,APR术后患者总体预后较差。
目的:比較低位直腸癌經腹會陰聯閤切除術(APR)和前切除術(AR)後的臨床療效。方法迴顧性分析北京大學人民醫院1998年1月至2010年12月間接受APR(151例,APR組)和AR(158例,AR組)術式的低位直腸癌患者的臨床資料,比較兩組短期結跼指標、跼部複髮率、總生存率及無進展生存率。結果 APR組較AR組患者的手術時間長[(268.5±66.7) min比(247.4±64.2) min,P=0.005],術中齣血量[(668.5±680.1) ml比(441.8±478.6) ml,P=0.001]和術後引流量多[(66.9±54.7) ml比(49.0±45.9) ml,P=0.002]。兩組患者跼部複髮率的差異無統計學意義( P=0.188),但對于T3~T4期患者,APR組患者的5年跼部複髮率(24.9%)明顯高于AR組(13.9%)(P=0.038)。腫瘤下緣距肛門4~6 cm的T3~T4期APR組患者的5年跼部複髮率(27.5%)明顯高于AR組(13.0%)(P=0.038)。兩組的總生存率和無進展生存率的差異均無統計學意義(均P>0.05);但噹體質量指數大于或等于24 kg/m2時,APR組T3~T4期患者的5年總生存率(43.1%)和無進展生存率(42.8%)均明顯低于AR組(87.9%和76.9%,P=0.022和P=0.041)。結論低位直腸癌APR和AR術後患者總體預後相噹,但噹患者腫瘤位于距肛緣4~6 cm、T3~T4分期和肥胖時,APR術後患者總體預後較差。
목적:비교저위직장암경복회음연합절제술(APR)화전절제술(AR)후적림상료효。방법회고성분석북경대학인민의원1998년1월지2010년12월간접수APR(151례,APR조)화AR(158례,AR조)술식적저위직장암환자적림상자료,비교량조단기결국지표、국부복발솔、총생존솔급무진전생존솔。결과 APR조교AR조환자적수술시간장[(268.5±66.7) min비(247.4±64.2) min,P=0.005],술중출혈량[(668.5±680.1) ml비(441.8±478.6) ml,P=0.001]화술후인류량다[(66.9±54.7) ml비(49.0±45.9) ml,P=0.002]。량조환자국부복발솔적차이무통계학의의( P=0.188),단대우T3~T4기환자,APR조환자적5년국부복발솔(24.9%)명현고우AR조(13.9%)(P=0.038)。종류하연거항문4~6 cm적T3~T4기APR조환자적5년국부복발솔(27.5%)명현고우AR조(13.0%)(P=0.038)。량조적총생존솔화무진전생존솔적차이균무통계학의의(균P>0.05);단당체질량지수대우혹등우24 kg/m2시,APR조T3~T4기환자적5년총생존솔(43.1%)화무진전생존솔(42.8%)균명현저우AR조(87.9%화76.9%,P=0.022화P=0.041)。결론저위직장암APR화AR술후환자총체예후상당,단당환자종류위우거항연4~6 cm、T3~T4분기화비반시,APR술후환자총체예후교차。
Objective To compare clinical efficacy between abdominoperineal resection (APR) procedure and anterior resection (AR) procedure in patients with rectal cancer. Methods Clinicopathological data of 309 cases with rectal cancer undergoing resection in Peking University People′s Hospital from January 1998 to December 2012 were retrospectively analyzed. Short-term outcomes, local recurrence, overall survival (OS) and progression-free survival (PFS) were investigated between two groups. Results As compared to the AR group, the operative time was longer [(268.5± 66.7) min vs. (247.4±64.2) min, P=0.005], blood loss[(668.5±680.1) ml vs.(441.8±478.6) ml, P=0.001] and drainage volume were more [(66.9±54.7) ml vs. (49.0±45.9) ml, P=0.002] in the APR group. There was no significant difference of local recurrence between the two groups, while the 5-year local recurrence rate of T3~T4 patients undergoing APR procedure (24.9%) was higher than that of AR group (13.9%)(P=0.038), especially in the patients with tumors located at 4-6 cm away from the anus verge. There were no significant differences of OS (P=0.273) and PFS (P=0.589) between two groups, while both 5-year OS and PFS of T3-T4 patients with BMI≥24 undergoing APR procedure (43.1% and 42.8%) were significantly worse than those of patients undergoing AR procedure (87.9% and 76.9%, P=0.022 and P=0.041). Conclusions The overall prognosis of patients after APR and AR iscomparable. Tumor located at 4-6 cm away from the anus verge, T3-T4 stage, obese may play an important role in the worse prognosis of the patients undergoing APR procedure.